254 related articles for article (PubMed ID: 11300936)
1. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
Cina SJ; Lancaster-Weiss KJ; Lecksell K; Epstein JI
Arch Pathol Lab Med; 2001 May; 125(5):646-51. PubMed ID: 11300936
[TBL] [Abstract][Full Text] [Related]
2. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
Yin H; Leong AS
Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of atypical papillary urothelial hyperplasia.
Swierczynski SL; Epstein JI
Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
[TBL] [Abstract][Full Text] [Related]
4. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of the urothelial tumors of the urinary bladder.
Helpap B; Köllermann J
Hum Pathol; 2000 Jun; 31(6):745-50. PubMed ID: 10872670
[TBL] [Abstract][Full Text] [Related]
5. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Navone R
Am J Surg Pathol; 2001 Dec; 25(12):1528-33. PubMed ID: 11717543
[TBL] [Abstract][Full Text] [Related]
6. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
7. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
8. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
9. p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder.
Sun W; Zhang PL; Herrera GA
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):327-31. PubMed ID: 12607601
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
12. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
13. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
[TBL] [Abstract][Full Text] [Related]
14. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB
Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Differentiation between Urothelial Papillomas and Papillary Neoplasms of Low Malignant Potential of the Urinary Bladder.
Alrashidy M; Atef A; Baky TA
Asian Pac J Cancer Prev; 2016; 17(4):1769-72. PubMed ID: 27221850
[TBL] [Abstract][Full Text] [Related]
16. [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].
Helpap B; Köllermann J
Pathologe; 2000 May; 21(3):211-7. PubMed ID: 10900613
[TBL] [Abstract][Full Text] [Related]
17. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendations.
Bang H; Park H; Park S; Choi E; Cho MS; Sung SH; Choi SY; Cho YM; Jeong SU; Ro JY
Ann Diagn Pathol; 2020 Feb; 44():151433. PubMed ID: 31785538
[TBL] [Abstract][Full Text] [Related]
19. The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?
Epstein JI
Crit Rev Oncol Hematol; 2003 Aug; 47(2):83-9. PubMed ID: 12900003
[TBL] [Abstract][Full Text] [Related]
20. Urothelial papilloma of the bladder: a review of 34 de novo cases.
Magi-Galluzzi C; Epstein JI
Am J Surg Pathol; 2004 Dec; 28(12):1615-20. PubMed ID: 15577681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
